SMI, headed by a doctor, never neglects research so as to respond most effectively to the needs of its customers by developing innovative projects.

“TETRAPAL” project

For one of its major customers (ExxonMobil) SMI, with the Institute of Tropical Medicine of the Health Service of the French armed forces, is coordinating the “TETRAPAL” project.

Researchers involved in this project are developing test strips (urinary) to enable health managers in businesses to ensure the taking of chemoprophylactic anti-malaria treatments by their staff during a period in a malaria zone.

These tests will also have a teaching role because they will serve as tools of exchange and promote responsibility in individuals.

The experiments and field tests are due to be completed at the end of the first half of 2010. This innovative product will be distributed exclusively by SMI as soon as it is available for sale, at the beginning of 2011.
   
“Remote Control Aid” program 

SMI is working on the “Remote Control Aid” program in partnership with Europ’ Assistance and Doctor Jean-Yves Chauve, doctor for ocean racing (notably the renowned Vendée Globe), a specialist in remote treatment of sailors and author of the famous “Guide to Remote Medicine”.These three areas of expertise are used to a develop a solution of accompanied medical assistance, with the help of the best means, which are:

- Diagnosis
- Rapid treatment
- Health equipment

The objective is to allow any individual, whatever language he speaks or situation he is in, on land or sea, to have the means of rapid evaluation of his condition and perfectly adapted treatment.
The concept has already been presented to the press in 2008.
   

Research on Malaria antibodies  

Parallel to these two projects, SMI is committed to basic anti-malaria research, in partnership with :

- one of its major customers (CGGVeritas)
- research scientists of the IRD (ex-ORSTOM),

SMI is contributing to a research project whose aim is to discover a means of identifying the antibodies secreted by a person bitten by a female anopheles that is carrying malaria parasites.This would allow, most notably, workers in an at-risk zone, to know the probabilities of contracting malaria and so know whether the anti-malaria chemoprophylactic should be continued.
   
SMI is constantly looking for new projects and is developing new health solutions able to respond to the various and evolving needs of professionals and travelers.

For example, SMI was able to react to a critical health situation caused by the A H1N1 flu of the summer of 2009, by offering a total solution to businesses as part of their plans for maintaining activity.